Evommune, Inc.
(NYSE: EVMN)
Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.
22.000
+0.070
(+0.32%)
Range
22.000 - 22.490
(2.23%)
Open
22.000
Previous Close
21.930
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
7,466
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
